“ú–{–òŠw‰ï ‘æ136”N‰ïi‰¡•lj@2016”N3ŒŽ26“ú(“y)E27“ú(“ú)E28“ú(ŒŽ)E29“ú(‰Î)@–k—¢‘åŠw–òŠw•” Œö‰vŽÐ’c–@l “ú–{–òŠw‰ï Œö‰vŽÐ’c–@l “ú–{–òŠw‰ï Œö‰vŽÐ’c–@l “ú–{–òŠw‰ï FAQ

3ŒŽ27“ú(æ—¥)@9:00~11:00@F‰ïê パシフィコ横浜 会議センター 3F 311+312
GS01
次世代型創薬ã®å¯èƒ½æ€§ã‚’探る ―既承èªè–¬ãƒ»é–‹ç™ºä¸­æ­¢å“ã®å¿œç”¨ã‚’指å‘ã—ãŸç ”究―
Seeking the Prospects for Next-Generation Drug Discovery—Toward New Uses of Existing Drugs for New Indications—
オーガナイザー:鈴木 ä¿Šç« ã€æ²¢å´Ž 綾一

GS01-1
既承èªè–¬ãƒ©ã‚¤ãƒ–ラリーを用ã„ãŸæ–°è¦ãƒ‰ãƒ©ã‚¤ã‚¢ã‚¤æ²»ç™‚è–¬ã®æŽ¢ç´¢
Search of the new therapeutic drug for dry eye syndrome using the approved medicines library
ƒVƒ“ƒ|ƒWƒXƒg F ○沢崎 綾一ã€çŸ³åŽŸ 知明ã€æ°´å³¶ å¾¹

GS01-2
フルオロキノロン系抗èŒè–¬ã«ã‚ˆã‚‹ç¶²è†œç´°èƒžä¿è­·ä½œç”¨
Protective effect of fluoroquinolones in cultured retinal cell line
ƒVƒ“ƒ|ƒWƒXƒg F ○久世 祥己ã€è¥¿ç”° å´‡ã€æœ›æœˆ 清文ã€å¶‹æ¾¤ é›…å…‰ã€å±±æœ¬ 哲也ã€åŽŸ 英彰

GS01-3
メラノーマ治療薬ã¨ã—ã¦é–‹ç™ºã•ã‚ŒãŸMEK阻害剤ã®å¤§è…¸ãŒã‚“治療薬ã¨ã—ã¦ã®å¯èƒ½æ€§
Drug repositioning of MEK inhibitor, originally developed for melanoma, to the agent for colon cancer
ƒVƒ“ƒ|ƒWƒXƒg F ○四方 雄貴ã€æœ¨æˆ‘ 真基ã€ç”°ä»£ 悦ã€äº•æœ¬ 正哉

GS01-4
既存医薬å“を用ã„ãŸãƒˆãƒªãƒ—ルãƒã‚¬ãƒ†ã‚£ãƒ–ä¹³ãŒã‚“ã®æ–°è¦æ²»ç™‚戦略
New Therapeutic Strategy and Drug Repositioning for Triple Negative Breast Cancer
ƒVƒ“ƒ|ƒWƒXƒg F â—‹æ¾äº• åƒç´˜ã€ä¸­ç€¬ 朋å¤ã€å·åŽŸ ã•ã¨å®Ÿã€é«™æ©‹ 幸一

GS01-5
ゾレドロン酸ã¨ãƒ•ãƒ«ãƒã‚¹ã‚¿ãƒãƒ³ã®ä½µç”¨ã«ã‚ˆã‚‹ãƒ’ト膵臓ãŒã‚“細胞増殖抑制ã®å¢—強効果
Synergistic antiproliferation effect on human pancreatic cancer by combination of zoledronic acid and fluvastatin
ƒVƒ“ƒ|ƒWƒXƒg F ○岡 雄平ã€å°æž— 大介ã€çªªç”° æ•å¤«ã€EL-SAYED Mahitabã€å³¶æ·» 隆雄

GS01-6
Bile salt export pump (BSEP)/ABCB11ã®éºä¼å­å¤‰ç•°ã«èµ·å› ã™ã‚‹é›£æ²»æ€§å°å…è‚内胆æ±ã†ã£æ»žç—‡ã«å¯¾ã™ã‚‹æ²»ç™‚è–¬ã®é–‹ç™º
Development of new drug for familial intrahepatic cholestasis
ƒVƒ“ƒ|ƒWƒXƒg F ○廣瀬 å‹ã€æž— ä¹…å…ã€æ¥ åŽŸ 洋之

GS01-7
消化管GVHD治療薬ã¨ã—ã¦ã®çµŒå£ãƒ™ã‚¯ãƒ­ãƒ¡ã‚¿ã‚¾ãƒ³è£½å‰¤
Oral beclomethazone dipropionate for the treatment of gastroinestinal GVHD
ƒVƒ“ƒ|ƒWƒXƒg F ○三谷 å¥äººã€å²¸ä¸Š ã•ã‚„ã‹ã€å¾Œè—¤ 梓沙ã€æž— 寛å­ã€å…¼æ‘ ä¿¡å®ã€æ›½ç”° ç¿ ã€éˆ´æœ¨ 昭夫ã€ç¬ åŽŸ åƒå—£ã€é¶´è¦‹ 寿ã€ä¼Šè—¤ å–„è¦ã€åŒ—市 清幸

GS01-8
Potential restoration of memory impairment in dementia by the Kampo formulation, nobiletin-rich chinpi-containing yokukansankachinpihange
Potential restoration of memory impairment in dementia by the Kampo formulation, nobiletin-rich chinpi-containing yokukansankachinpihange
ƒVƒ“ƒ|ƒWƒXƒg F â—‹GUTIERREZ RICO Evelynã€å¾ 寧ã€å·ç•‘ 伊知郎ã€å®‰è—¤ 英広ã€å‰ç”° 雅昭ã€å±±åœ‹ å¾¹

GS01-9
Oxaliplatinã«ã‚ˆã‚‹æœ«æ¢¢ç¥žçµŒéšœå®³æ€§ç–¼ç—›ã«å¯¾ã™ã‚‹äººå‚養栄湯ã®æœ‰åŠ¹æ€§ã®æ¤œè¨Ž
Relieving effect of ninjin’yoeito on oxaliplatin-induced neuropathic pain
ƒVƒ“ƒ|ƒWƒXƒg F ○鈴木 ä¿Šç« ã€å±±æœ¬ 彩乃ã€å¤§æ¾¤ 匡弘ã€å…ƒé›„ 良治ã€æ°´ä¸Š å…ƒã€ç‰§é‡Ž 利明

ŒŸõƒy[ƒW‚É–ß‚é

TOP‚Ö–ß‚é
ƒvƒ‰ƒCƒoƒV[ƒ|ƒŠƒV[‚ɂ‚¢‚Ä
@Copyright (C) Œö‰vŽÐ’c–@l“ú–{–òŠw‰ï